Goldman School of Public Policy, University of California, Berkeley, CA, USA.
J Gen Intern Med. 2010 Nov;25(11):1172-7. doi: 10.1007/s11606-010-1424-8. Epub 2010 Jun 23.
Patient-physician race/ethnicity and language concordance may improve medication adherence and reduce disparities in cardiovascular disease (CVD) by fostering trust and improved patient-physician communication.
To examine the association of patient race/ethnicity and language and patient-physician race/ethnicity and language concordance on medication adherence rates for a large cohort of diabetes patients in an integrated delivery system.
We studied 131,277 adult diabetes patients in Kaiser Permanente Northern California in 2005. Probit models assessed the effect of patient and physician race/ethnicity and language on adherence to CVD medications, after controlling for patient and physician characteristics.
Ten percent of African American, 11 % of Hispanic, 63% of Asian, and 47% of white patients had same race/ethnicity physicians. 24% of Spanish-speaking patients were linguistically concordant with their physicians. African American (46%), Hispanic (49%) and Asian (52%) patients were significantly less likely than white patients (58%) to be in good adherence to all of their CVD medications (p<0.001). Spanish-speaking patients were less likely than English speaking patients to be in good adherence (51% versus 57%, p<0.001). Race concordance for African American patients was associated with adherence to all their CVD medications (53% vs. 50%, p<0.05). Language concordance was associated with medication adherence for Spanish-speaking patients (51% vs. 45%, p<0.05).
Increasing opportunities for patient-physician race/ethnicity and language concordance may improve medication adherence for African American and Spanish-speaking patients, though a similar effect was not observed for Asian patients or English-proficient Hispanic patients.
患者与医生的种族/民族和语言一致性可以通过增强信任和改善医患沟通来提高药物治疗依从性并减少心血管疾病(CVD)的差异。
在一个综合医疗系统中,研究大量糖尿病患者,以检验患者种族/民族和语言以及患者与医生种族/民族和语言一致性与药物治疗依从性之间的关系。
我们研究了 2005 年 Kaiser Permanente 北加利福尼亚的 131277 名成年糖尿病患者。在控制了患者和医生的特征后,使用概率模型评估了患者和医生的种族/民族和语言对 CVD 药物治疗依从性的影响。
10%的非裔美国人、11%的西班牙裔、63%的亚裔和 47%的白人患者有相同种族/民族的医生。24%的讲西班牙语的患者与他们的医生语言一致。非裔美国人(46%)、西班牙裔(49%)和亚裔(52%)患者与白人患者(58%)相比,药物治疗依从性明显较差(p<0.001)。讲西班牙语的患者与讲英语的患者相比,药物治疗依从性较差(51%对 57%,p<0.001)。非裔美国患者的种族一致性与他们所有 CVD 药物的治疗依从性相关(53%对 50%,p<0.05)。语言一致性与讲西班牙语的患者的药物治疗依从性相关(51%对 45%,p<0.05)。
增加患者与医生种族/民族和语言一致性的机会可能会提高非裔美国人和西班牙语患者的药物治疗依从性,但对亚裔患者或讲英语的西班牙裔患者则没有类似的效果。